Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs

194 indexed citations

Abstract

loading...

About

This paper, published in 2021, received 194 indexed citations. Written by Xin Chen, Ronghua Jin, Lu Chen, Ming Dang, Hao Cao, Yun Dong, Bolei Cai, Guo Bai, J. Justin Gooding and Shiyu Liu covering the research area of Molecular Biology, Surgery and Biomaterials. It is primarily cited by scholars working on Molecular Biology (81 citations), Biomaterials (78 citations) and Surgery (77 citations). Published in Science Advances.

Countries where authors are citing Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs

Specialization
Citations

This map shows the geographic impact of Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs more than expected).

Fields of papers citing Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1126/sciadv.abd6740.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026